Literature DB >> 12539174

Biology of angiogenesis in tumors of the gastrointestinal tract.

Niels Reinmuth1, Alexander A Parikh, Syed A Ahmad, Wenbiao Liu, Oliver Stoeltzing, Fan Fan, Akihiko Takeda, Morihisa Akagi, Lee M Ellis.   

Abstract

The realization that the growth and spread of tumors are dependent on angiogenesis has created new avenues of research designed to help us to better understand cancer biology and to facilitate the development of new therapeutic strategies. However, the process of angiogenesis consists of multiple, sequential, and interdependent steps with a myriad of positive and negative regulators of angiogenesis being involved. The survival of tumors and thus their metastases are dependent upon the balance of endogenous angiogenic and anti-angiogenic factors such that the outcome favors increased angiogenesis. Several growth factors have been identified that regulate angiogenesis in cancers of the gastrointestinal tract. These include pro-angiogenic factors like vascular endothelial growth factor (VEGF) and anti-angiogenic factors, i.e., thrombospondin. The following review provides a brief overview about the most important factors that are involved in the angiogenic process in tumors derived from colon, stomach, and pancreas. A thorough understanding of the role these factors play in the angiogenic process may lead to the development of novel therapeutic antineoplastic strategies. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12539174     DOI: 10.1002/jemt.10258

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  29 in total

1.  Targeting angiogenesis in gastroesophageal cancer: industry-sponsored trials are not the answer.

Authors:  Sarah K Thompson
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

2.  Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Authors:  Matilde Lombardero; Sergio Vidal; Robert Hurta; Alba Román; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 3.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 4.  Current directions in chemotherapy for colorectal cancer.

Authors:  Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

5.  Effect of 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid in combination with carboplatin on gastric carcinoma growth in vivo.

Authors:  Jin-Lian Chen; Jin-Shui Zhu; Jing Hong; Ming-Xiang Chen; Jin-Lai Lu; Wei-Xiong Chen; Bo Shen; Zu-Ming Zhu; Ni-Wei Chen
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

6.  Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors.

Authors:  Luciana Regina Moreira; André Almeida Schenka; Paulo Latuf-Filho; André Lisboa Penná; Carmen S P Lima; Fernando Augusto Soares; Miriam Aparecida Silva Trevisan; José Vassallo
Journal:  Tumour Biol       Date:  2011-01-08

7.  Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Dimitrios Stefanou; Anna Batistatou; Niki J Agnantis
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

8.  A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer.

Authors:  Yunfei Cao; Aihua Tan; Feng Gao; Lidan Liu; Cun Liao; Zengnan Mo
Journal:  Int J Colorectal Dis       Date:  2009-01-30       Impact factor: 2.571

9.  Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Authors:  Kyung A Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Jin-Yeong Han; Kyeong Hee Kim; Ri Young Goh; Hong Jo Choi; Ki Jae Park; Mee Sook Roh; Hyo-Jin Kim; Hyuk-Chan Kwon; Jong Hoon Lee
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

10.  The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.

Authors:  Seong-Eun Kim; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Joo Ho Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.